Abacus targets $450 million in adjusted EBITDA by 2030

Abacus Global Management  is targeting $450 million in adjusted EBITDA by 2030 as it looks to generate more recurring revenue from asset management, wealth management and its lifespan technology.

Speaking at the company’s investor day, COO and CFO William McCauley said Abacus expects adjusted EBITDA to reach $250 million in 2028, up from approximately $135 million in 2025.

The company is aiming to increase fee-based recurring revenue from 16% today to 70% by 2030. Its Life Solutions division, which includes the company’s life settlement operations, currently generates approximately 84% of total revenue. Abacus expects that share to decline to 40% in 2028 and 30% in 2030 as its other businesses grow.

Abacus reported $235 million in revenue and $133 million in adjusted EBITDA for 2025. First-quarter 2026 revenue increased 34.6% year-over-year to $59.4 million, while adjusted EBITDA reached $32.7 million.

For 2026, the company is guiding for adjusted net income of $100 million to $106 million and more than $5 billion in assets under management by year-end. It is also targeting $3 million in revenue from Abacus Intel.

A key part of the strategy is LifeARC, an actuarial risk calculator that uses medical records and mortality data to estimate an individual’s lifespan and incorporate that information into financial planning. Abacus is testing the technology with Manning & Napier, the $18 billion asset manager and investment advisor in which it holds a minority stake.

CEO Jay Jackson described Abacus as seeking to become the “market maker of time.”

“We’re reframing the question that says, instead, how long will it last? And then we’re going to say, how much do you want to spend?” Jackson said, referring to retirement planning.

Abacus is considering an annual, asset-based or revenue-sharing pricing model for LifeARC, although it has not disclosed pricing. Management said revenue generated by LifeARC and Abacus Intel should carry higher margins than the company’s core life settlement business.

The company’s asset management operation currently oversees more than $3.5 billion, including over $2.5 billion in longevity funds and more than $700 million in exchange-traded fund assets. Abacus raised nearly $1 billion for its income funds over 15 months and expects to exceed $500 million in inflows through the second quarter of 2026.

Longer term, Abacus is targeting at least $10 billion in assets under management. It also plans to place its entire portfolio on blockchain by year-end, with a little over 100 assets already recorded on the technology.

“We expect to be the gold standard for all things longevity and lifespan investing,” said Corey McLaren, managing director of capital markets.

Bottom Line: The word Coventry never came up.